申请人:AbbVie Inc.
公开号:US20130158067A1
公开(公告)日:2013-06-20
Disclosed herein are compounds of formula (I):
or pharmaceutically acceptable salts thereof, wherein X
1
, L, R
x
, R
y
, R
z
, A, m, n, p, q, s, and positions a and b are as defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also disclosed.
披露于此的是公式(I)的化合物:
或其药用可接受的盐,其中X
1
,L,R
x
,R
y
,R
z
,A,m,n,p,q,s,以及位置a和b如说明书所述定义。还披露了包含此类化合物的组合物以及使用此类化合物和组合物治疗状况和失调的方法。